New Year Challenges and Promises in Europe
The EMA's predictions are a measure of optimism against a rather somber background.
EMA Ends 2012 with a Flourish - and a 4.1% Budget Rise
How CRO Worldwide Clinical Trials is Approaching eTMF
2013 Predictions for Clinical Development
New Frontiers in Clinical Trial Data Collection
Benchmarking Investigator Payments
Politics and Medical Research
Adaptive Trial Market Dynamics
Healing Europe's Jobs Disease
Healthcare is seen as one of the most promising sectors to help boost EU employment.
Thinking of Phase IV Trials? The EU May See Things Differently!
Electronic Clinical Trials and the Expectations of the Regulatory Agencies
Is There Proof that CRO and Sponsor Strategic Alliances Save Costs and Add Value?
Can a Central IRB Improve Efficiency?
Adaptive Trial Design: From a Recruiter's Perspective
EU Health Leadership Still Hanging in the Balance
Diabetes Research in Clinical Trials
Clinical Trials Caught in the Fallout From Dalli-Gate
A Word About Unsustainable Costs
Taking the Pulse of Ethics Committee Views
Will ethics committees buy into the radical new approach of latest draft regulation?
Hepatitis C Report
Yesterday's News on Conflicts of Interest at the EMA
Are Cardiovascular Problems Ever Not a Risk?
Good Thing Generics Were Elevated
CDISC Responds to TransCelerate Questions
Patient Experiences Equal Engagement
How are the Children Doing?
The European Union is preparing a report on the lessons learned from its 2006 pediatric regulation.
A Time Bomb Inside the New European Rules on Clinical Trials?
Biostatisicians Can Improve Trial Design
The Valley of Death
Clinipace CEO Discusses Most Recent Acquisition
